Zika

According to a report by Reuters, researchers in the U.S. began the first clinical trial of a Zika vaccine, but there is one major issue. The Obama Administration said on Wednesday that funds allocated toward combating the Zika virus will run out soon due to congressional inaction. Unfortunately,...

There are at least two stocks -- Intrexon Corporation (NYSE: XON) and Inovio Pharmaceuticals, Inc. (NASDAQ: INO) -- that continued to get more attention from investors. That's because these stocks and Cerus Corporation (NASDAQ: CERS) shares are likely to gain from the Zika Virus. The threat...

On Friday, reports were released regarding Zika's progression in Florida causing some travel and treatment stocks to move sharply. Florida Governor's Report Florida Governor Rick Scott announced Friday Morning that no mosquitoes had tested positive for Zika; however, four cases of the virus had...

The Zika virus has swarmed media outlets as the mosquito-borne disease spreads. Over the past six months, the scare has escalated from an issue concerning South America to a woman's and ethical issue — as bans against pregnancy in certain countries following the discovery that the virus can...

The first Zika-virus related death within the Continenal U.S. was confirmed over the weekend. According to NBC News, officials in Salt Lake said a patient contracted the Zika virus which ultimately led to her demise at the end of June. Health officials suspect there are thousands of people that...

Intrexon Corp (NYSE: XON) faces a large, multi-segment market opportunity, which outweighs near-term pressures related to its 2Q16 results, Wunderlich’s Ryan MacDonald said in a report. He reiterated a Buy rating on the company, with a price target of $50. Intrexon’s Oxitec business...

Five weeks before the 2016 Olympics are to be held in Rio de Janeiro, the news is awash with embarrassing and in some cases downright gruesome headlines that call into question the safety or even feasibility of holding the games in Rio. Last week, a human foot washed up on Copacabana beach,...

Following closely on the heels of news that the U.S. Senate failed to pass legislation to fund development of a vaccine to combat the Zika virus, a poll revealed Thursday that the majority of Americans want to spend the money. Related Link: Will Senate Recess Without Approving Zika Funding Amid...

Given Popular Inc (NASDAQ: BPOP)'s excess capital and valuation discount to U.S. peers, Barclays’ Matthew J. Keating believes the stock offers an “interesting” intermediate term investment option. Keating initiated coverage of Popular with an Equal-Weight rating and price target...

Hologic, Inc. (NASDAQ: HOLX) shares outperformed very modestly Monday following news the company and Grifols' Zika virus assay received FDA approval. The stock closed up nearly 1 percent versus a 0.73 percent rally in the Dow Jones Industrial Average and a 0.58 percent increase in the S&P...

Shares of OraSure Technologies, Inc. (NASDAQ: OSUR) are up 20 percent year-to-date. Raymond James’ Nicholas Jansen downgraded the rating for the company from Outperform to Market Perform, saying the shares were within 3 percent of the previous price target of $8. Factors Driving...

Bill and Melinda Gates Foundation have partnered with the private sector to fight Zika amid the World Health Organization (WHO) warnings that people living in Zika-affected nations to delay pregnancy due to the virus' potential impact on children, according to a report on Fox Business Network. "I...

Brazil has seen so many changes in its political leadership. What’s relevant to this piece is the following: Over the past couple of months, the Latin American country, which will be hosting the 2016 Summer Olympic Games in less than three months, has gone through three Sports Ministers....

The World Health Organization (WHO) has advised people returning from Zika-virus infected areas should either abstain from sex or practice safe sex for eight weeks, according to a Reuters report. Previously, the WHO had announced a four-week "safe" period. "The recommendation, which doubles the...